相关实验视频

Updated: Jul 8, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

TIM-3阻塞:DIPG中的免疫和向疗法

Yan Hu¹, Peishan Hu², Xiaozhong Peng³

¹Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, Chengdu, China.

Trends in molecular medicine

|December 13, 2023

概括

蒂姆-3阻塞为扩散内在结质瘤 (DIPG) 提供了一种新的治疗策略. 这种方法针对癌细胞并调节免疫微环境,为这种具有挑战性的儿科脑瘤提供了一个有希望的途径.

科学领域:

神经瘤学神经瘤学
免疫治疗是一种免疫疗法.
癌症生物学癌症生物学

背景情况:

扩散内在庞丁质瘤 (DIPG) 是一种高度攻击性的儿科脑瘤,治疗选择有限.
传统疗法对DIPG的有效性很小,这凸显了对新型治疗策略的需求.
针对性治疗和免疫瘤学的进步为DIPG治疗提供了潜在的途径.

研究的目的:

调查TIM-3阻塞作为扩散内在庞丁质瘤治疗策略的潜力.
评估TIM-3阻断在准DIPG癌细胞和调节瘤免疫微环境中的双重作用.

主要方法:

这项由Ausejo-Mauleon等人进行的研究. (癌细胞) 在DIPG的背景下探索了TIM-3封锁.
研究可能涉及到临床前模型或对瘤微环境的分析,以评估治疗疗效.

主要成果:

蒂姆-3阻塞显示出同时向DIPG癌细胞的潜力.
该策略还在调节瘤内的免疫微环境方面表现有前途.
这种双重机制表明了克服DIPG治疗耐药性的新方法.

结论:

蒂姆-3阻塞代表了扩散内在庞丁质瘤的潜在突破性治疗方法.
准TIM-3提供了一个有前途的策略,以解决DIPG中的癌细胞和免疫场景.
对TIM-3阻塞的进一步研究可能会为DIPG患者带来更好的结果.

关键词:

这就是DIPG.在TIM-3中,TIM-3是TIM-3.免疫疗法免疫疗法有针对性的治疗.

更多相关视频

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...